14,000
Participants
Start Date
February 24, 2021
Primary Completion Date
March 31, 2025
Study Completion Date
March 31, 2025
Magnetic Resonance Imaging
Patients who underwent MRI with confirmed pathology data (either biopsy or prostatectomy)
Fondazione del Piemonte per l'Oncologia, Candiolo
Collaborators (1)
Fundacao Champalimaud
OTHER
Stichting Katholieke Universiteit
OTHER
Fundacion Para La Investigacion Hospital La Fe
OTHER
University of Pisa
OTHER
Institut Paoli-Calmettes
OTHER
Hacettepe University
OTHER
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
OTHER
JCC DIAGNOSTIC IMAGING
UNKNOWN
National Cancer Institute (NCI)
NIH
Agios Savas
UNKNOWN
Royal Marsden NHS Foundation Trust
OTHER
QS INSTITUTO DE INVESTIGACION E INNOVACION SL
UNKNOWN
IDRYMA TECHNOLOGIAS KAI EREVNAS
UNKNOWN
"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"
OTHER_GOV
THE GENERAL HOSPITAL CORPORATION
UNKNOWN
BIOTRONICS 3D LIMITED
UNKNOWN
Advantis Medical Imaging
UNKNOWN
QUIBIM SOCIEDAD LIMITADA
UNKNOWN
University of Vienna
OTHER
Fondazione del Piemonte per l'Oncologia
OTHER